Our previous study on SOX9 expression in a large number of DLBCL patient samples revealed high SOX9 expression in a subset of patients with GCB DLBCL harbouring the IGH/BCL2 translocation, which frequently results in elevated BCL2 expression. This evidence concerns the gene SOX9 and diffuse large B-cell lymphoma.